Abstract:Aging is associated with a decline in skeletal muscle mass and function-termed sarcopenia-as mediated, in part, by muscle anabolic resistance. This metabolic phenomenon describes the impaired response of muscle protein synthesis (MPS) to the provision of dietary amino acids and practice of resistance-based exercise. Recent observations highlight the gut-muscle axis as a physiological target for combatting anabolic resistance and reducing risk of sarcopenia. Experimental studies, primarily conducted in animal models of aging, suggest a mechanistic link between the gut microbiota and muscle atrophy, mediated via the modulation of systemic amino acid availability and low-grade inflammation that are both physiological factors known to underpin anabolic resistance. Moreover, in vivo and in vitro studies demonstrate the action of specific gut bacteria (Lactobacillus and Bifidobacterium) to increase systemic amino acid availability and elicit an anti-inflammatory response in the intestinal lumen. Prospective lifestyle approaches that target the gut-muscle axis have recently been examined in the context of mitigating sarcopenia risk. These approaches include increasing dietary fiber intake that promotes the growth and development of gut bacteria, thus enhancing the production of short-chain fatty acids (SCFA) (acetate, propionate, and butyrate). Prebiotic/probiotic/symbiotic supplementation also generates SCFA and may mitigate low-grade inflammation in older adults via modulation of the gut microbiota. Preliminary evidence also highlights the role of exercise in increasing the production of SCFA. Accordingly, lifestyle approaches that combine diets rich in fiber and probiotic supplementation with exercise training may serve to produce SCFA and increase microbial diversity, and thus may target the gut-muscle axis in mitigating anabolic resistance in older adults. Future mechanistic studies are warranted to establish the direct physiological action of distinct gut microbiota phenotypes on amino acid utilization and the postprandial stimulation of muscle protein synthesis in older adults.

Sarcobesity: new paradigms for healthy aging related to taurine supplementation, gut microbiota and exercise

Targeting Inflammation and Downstream Protein Metabolism in Sarcopenia: A Brief Up-Dated Description of Concurrent Exercise and Leucine-Based Multimodal Intervention

Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets

Exercise and Nutrition Strategies to Counteract Sarcopenic Obesity

Sarcopenia: assessment of disease burden and strategies to improve outcomes

Sarcopenic obesity in older adults: a clinical overview

Editorial: Molecular mechanisms underlying exercise-alleviated sarcopenic obesity

Therapeutic strategies to modulate gut microbial health: Approaches for sarcopenia management

Sarcopenia: Etiology, Nutritional Approaches, and miRNAs

Treating Sarcopenia in Older and Oldest Old

Taurine Administration Counteracts Aging-Associated Impingement of Skeletal Muscle Regeneration by Reducing Inflammation and Oxidative Stress

The Gut-Muscle Axis in Older Subjects with Low Muscle Mass and Performance: A Proof of Concept Study Exploring Fecal Microbiota Composition and Function with Shotgun Metagenomics Sequencing

An Integrated Approach to Skeletal Muscle Health in Aging

Molecular and Cellular Aspects of Sarcopenia, Muscle Healthy Aging and Physical Conditioning in the Elderly

Nutritional Management and Physical Activity in the Treatment of Sarcopenic Obesity: A Review of the Literature

Sarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people

Recent Advances in Nutraceuticals for the Treatment of Sarcopenic Obesity

Mechanisms Linking the Gut-Muscle Axis With Muscle Protein Metabolism and Anabolic Resistance: Implications for Older Adults at Risk of Sarcopenia

Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective

Muscle aging and sarcopenia: The pathology, etiology, and most promising therapeutic targets

Sarcopenia, frailty and their prevention by exercise